- Home
- ROIV vs DOW Comparison
ROIV vs DOW Comparison
Compare ROIV & DOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | DOW |
|---|---|---|
| Founded | 2014 | 1897 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 16.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | DOW |
|---|---|---|
| Price | $21.33 | $24.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 15 |
| Target Price | $24.31 | ★ $27.00 |
| AVG Volume (30 Days) | 8.3M | ★ 10.5M |
| Earning Date | 02-09-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 5.77% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $20,329,000.00 | ★ $40,913,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $741.42 | $2.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $20.40 |
| 52 Week High | $23.47 | $42.17 |
Technical Indicators
Market Signals| Indicator | ROIV | DOW |
|---|---|---|
| Relative Strength Index (RSI) | 48.66 | 64.51 |
| Support Level | $21.36 | $22.77 |
| Resistance Level | $22.21 | $23.74 |
| Average True Range (ATR) | 0.73 | 0.61 |
| MACD | -0.17 | 0.11 |
| Stochastic Oscillator | 19.30 | 87.81 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.